The safety and efficacy of these methods have been well established through long - term
clinical outcomes studies in the field, with the nasal lining protecting the brain from infection just as the blood brain barrier has done.
Whereas enthusiasm for fasting is increasing, clinical relevance remains low because of insufficient human data, including almost nonexistent controlled trials (21, 33 — 36), few
clinical outcomes studies (37, 38), lack of correction for inflated type I error rates from multiple hypothesis tests, and limited safety data (39 — 41).
Of further note, despite the different designs, regimens, and study outcomes, the convergence of findings regarding fasting from the 2 epidemiologic
clinical outcomes studies (that arose due to data regarding smoking and CAD outcomes, i.e., references 37 and 38) and the findings of interventional studies (most having arisen as extensions of CR research, i.e., references 20, 25 — 36, 39, 40) suggests that a prudent amount of fasting beneficially influences health outcomes.
Studies whose endpoints were surrogate outcomes (e.g., weight loss, LDL cholesterol, and brain - derived neurotrophic factor) that themselves are predictors of clinical events were not considered to be
clinical outcomes studies.
Whereas the few randomized controlled trials and observational
clinical outcomes studies support the existence of a health benefit from fasting, substantial further research in humans is needed before the use of fasting as a health intervention can be recommended.
Designed and developed programs for the implementation of disease management products; and
clinical outcomes studies.
Not exact matches
Examples of forward - looking statements in this news release include statements regarding the effectiveness of the Company's products, the potential
outcome of
clinical studies, the future success of development activities and the future growth and operating and financial performance of the Company.
Amarin's
clinical development program for Vascepa includes a trial known as the REDUCE - IT cardiovascular
outcomes study, an 8,175 - patient
study commenced in 2011.
A search of Pubmed [a data base containing all medical journal articles] for platelet rich plasma yields 6,811 articles, but less than 20 are
clinical studies evaluating patient
outcomes for orthopedic sports medicine conditions.
The strengths of the
study include the ability to compare
outcomes by the woman's planned place of birth at the start of care in labour, the high participation of midwifery units and trusts in England, the large sample size and statistical power to detect clinically important differences in adverse perinatal
outcomes, the minimisation of selection bias through achievement of a high response rate and absence of self selection bias due to non-consent, the ability to compare groups that were similar in terms of identified
clinical risk (according to current
clinical guidelines) and to further increase the comparability of the groups by conducting an additional analysis restricted to women with no complicating conditions identified at the start of care in labour, and the ability to control for several important potential confounders.
The definition of low risk used in the cohort
study was based on criteria contained in the NICE Intrapartum Care Guidelines.11 The primary
clinical outcome was a composite measure of adverse perinatal
outcomes encompassing perinatal mortality and specified neonatal morbidities (box).
Subjects were identified from an ongoing pregnancy
outcome study conducted through the California Teratogen Information Service and
Clinical Research Program.
Detection bias has been avoided in this
study by equal surveillance of
clinical outcomes between the two feeding groups by the NICU staff and physicians.
Studies were included if: (a) they were RCTs, (b) the population comprised parents / carers of children up to the age of 18 where at least 50 % had a conduct problem (defined using objective
clinical criteria, the
clinical cut - off point on a well validated behaviour scale or informal diagnostic criteria), (c) the intervention was a structured, repeatable (manualised) parenting programme (any theoretical basis, setting or mode of delivery) and (d) there was at least one standardised
outcome measuring child behaviour.
Today, the DOC Band is the only device supported by
clinical studies and over 25 years of documented
outcomes.
It was found that the protective effect of breast - feeding was observed only when the analysis was restricted to
studies that used medical personnel to assess
clinical outcomes, such as atopic dermatitis.
Though
clinical studies show that technology is better at finding potential tumors, and less likely to result in false alarms, there is not yet long - term research to show whether it saves lives or otherwise improves
outcomes.
When subsequent
studies found that CellSearch results had no influence on
clinical outcomes, though, insurers lost interest in paying for it.
Placebos are used to help accurately measure
clinical responses /
outcomes when
studying the effects of medications, therapies, and other treatments.
«We believe these
studies and
clinical trials that combine immunotherapy with chemotherapy are advancing efforts toward better
clinical care and more positive
outcomes for our patients at CTCA,» said Dr. Vivek Khemka, Medical Oncologist, CTCA at Western and the WCLC
study abstract's principal investigator and senior author.
In observational
studies, researchers observe exposures and
outcomes for patients as they occur naturally in
clinical care or real life.
However, the
study provides initial
clinical evidence that larger, size - matched grafts have the potential to improve
outcomes when resurfacing cartilage defects of the femoral head in the hip joint.
«We saw that prevalence rates for depression and anxiety diagnoses were lower among racial and ethnic minorities compared to non-Hispanic whites,» said Owen - Smith, who worked at the Kaiser Permanente Georgia Center for
Clinical and
Outcomes Research when the
study was conducted.
In anticipation of targeted medicines, pharmaceutical and biotechnology companies are increasingly performing genetic
studies of
clinical trial participants in hopes of identifying genetic profiles that predict therapeutic
outcomes.
Since randomized
clinical trials — the gold - standard in research — don't accommodate patients» preferences, Zoellner and her research team used a
study design called a «doubly randomized preference trial» to investigate whether giving patients a choice affects their treatment
outcomes.
To accurately predict treatment
outcomes, the research team
studied JIA patients» treatment responses and found that epigenetics — or individuals» DNA and the way each body uses its genes — determined one's
clinical «fate.»
The next step, says Salem, will be to try to correlate these findings with patient treatment
outcomes, initially as a retrospective, or backward looking
study, and then hopefully design a forward looking
clinical trial to determine which treatments may be best for patients with SBAs.
In 22 percent of cases, the additional
clinical information found in the EHR was rated as «possibly» having a clinically significant impact on the interpretation of the head CT. «This
study exemplifies the power of EHR's and their potential impact on patient care and positive
outcomes.
A first - of - its - kind literature review published in the September issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists ® (ASA ®), suggests although a majority of
studies report positive
outcomes, there is currently insufficient evidence to support the
clinical use of antidepressants for the treatment of postoperative pain.
A new
study suggests that insomnia decreases empathy in health care workers and may lead to adverse
clinical outcomes and medical errors.
With survival rates improving for ARDS patients, understanding and improving their quality of life
outcomes is a
clinical and research priority, according to the
study's principal investigator Samuel M. Brown, MD, MS, FASE, director of the Center for Humanizing Critical Care at Intermountain Medical Center.
Surrogates often overstate a drug's effectiveness and imply beneficial effects twice as often as
studies recording actual
clinical outcomes.
The
study, Developing an Interventional Stroke Service: Improving
Clinical Outcomes and Reducing Cost and Delivering Great Cost Savings Benefits to Health Economy, conducted at the University Hospital of North Midlands, Stoke - on - Trent, U.K., found that mechanical thrombectomy (the use of a device to retrieve a clot from the vessel) in the treatment of stroke reduced the average stroke patient's hospital stay to 14 days when compared to previously recorded 90 days.
The UB researchers are conducting a longitudinal, five - year
study of these patients focused on the relationship between cerebral microbleeds, advances in magnetic resonance imaging and
clinical outcomes.
The
study, «Acceptance and Commitment Therapy to Manage Pain and Opioid Use after Major Surgery: Preliminary
Outcomes from the Toronto General Hospital Transitional Pain Service,» is published in the Canadian Journal of Pain, by first author Muhammad Azam, Ph.D. candidate at York University and senior authors Dr. Joel Katz, Affiliate Scientist, Toronto General Hospital Research Institute (TGHRI) and Dr. Hance Clarke, Director of the Transitional Pain Service at TGH, UHN and
Clinical Researcher, TGHRI.
The
study, published online in Radiology, is among the first to examine what cerebral microbleeds may mean for
clinical outcomes in MS.
In brain imaging
studies, the OPFC is highly active when people deliberate between actions with uncertain risks and rewards, and
clinical reports describe patients, such as Gage, whose inability to consider long - term consequences can lead to tragic
outcomes.
In three new
studies in the current issue of the International Journal of Infectious Disease, researchers reported on
clinical outcomes in the Kingdom of Saudi Arabia (KSA), how long patients will shed virus during their infections, and how the Sultanate of Oman is dealing with cases that have appeared there.
«New therapeutic strategies that target the molecular drivers of invasion are required for improved
clinical outcome,» said Dr. Harshil Dhruv, a TGen Research Assistant Professor and lead author of the
study.
A second objective of the
study was to assess the effect of anti-drug antibody (ADA) on
clinical outcomes.
Just four out of 33
studies reported
clinical outcomes that could be compared to any standard, while none of the
studies compared two or more sizing systems.
«We aren't using older stents anymore, so this
study gives us some insight into more up - to - date
clinical outcomes,» says Sripal Bangalore MD, an associate professor in NYU Langone's Leon H. Charney Division of Cardiology, Department of Medicine, who was lead author of the
study.
«The follow - up period was relatively short — six weeks — and the
study was not statistically powered to measure
clinical outcomes,» said Tindle, who served as the lead
study physician while working at the University of Pittsburgh through the summer of 2014.
«In conclusion, the
study by Carrero et al in this issue of JAMA provides the best evidence to date that vitamin K antagonists [anticoagulants] are associated with improved
clinical outcomes and no significant increased risk of bleeding in patients with myocardial infarction and atrial fibrillation with advanced CKD.»
In a new
study, a hospital surveillance program focusing on reducing the risks of sepsis, known as the two - stage
Clinical Decision Support (CDS) system, was found to reduce the risk of adverse
outcomes, such as death and hospice discharge for sepsis patients, by 30 % over the course of one year.
«Although hypothermia is a promising strategy to improve resuscitation and brain recovery following cardiac arrest, the results of the current
study do not support routine use of cold intravenous fluid in the prehospital setting to improve
clinical outcomes,» the authors write.
«Few
clinical interventions have had an impact on birth
outcomes,» said Professor Jeannette R. Ickovics, the
study's lead author.
«Previous
studies suggest that reducing heart fat is feasible through weight loss or weight management, but these
studies only looked at small numbers of people and there have been no
clinical trials linking cardiovascular
outcomes with heart fat changes due to weight management interventions.
«This is the first national
study to identify specific regions of the United States where residents may be at an increased risk for poor
clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the
study.
Shalowitz and colleagues suggest future
studies should focus on defining areas with poor
clinical outcomes attributed to geographic factors, and creating a comprehensive national, geographically - linked database on the utilization of gynecologic cancer care and
clinical outcomes.